839
Participants
Start Date
August 5, 2019
Primary Completion Date
August 28, 2024
Study Completion Date
June 10, 2026
Ipilimumab
Specified dose on specified days
Oxaliplatin
Specified dose on specified days
Leucovorin
Specified dose on specified days
Fluorouracil
Specified dose on specified days
Irinotecan
Specified dose on specified days
Bevacizumab
Specified dose on specified days
Cetuximab
Specified dose on specified days
Nivolumab
Specified dose on specified days
Local Institution - 0025, Anderlecht
Local Institution - 0065, Vienna
Local Institution - 0084, Buenos Aires
Local Institution - 0100, CABA
Local Institution - 0072, CABA
Local Institution - 0073, Ciudad Autonoma Beunos Aires
Local Institution - 0034, Lorenskog
Local Institution - 0019, Westmead
Local Institution - 0067, Wiener Neustadt
Local Institution - 0038, Herlev
Local Institution - 0045, Bonheiden
Local Institution - 0024, Leuven
Local Institution - 0017, Heidelberg
Local Institution - 0041, Clayton
Local Institution - 0068, Linz
Local Institution - 0053, Woolloongabba
Local Institution - 0120, Salzburg
Local Institution - 0033, Bergen
Local Institution - 0018, Elizabeth Vale
Local Institution - 0036, Vejle
Local Institution - 0064, Graz
Local Institution - 0074, Viedma
Local Institution - 0060, New York
Local Institution - 0222, Athens
Local Institution - 0123, Athens
Local Institution - 0066, Marseille
Local Institution - 0173, A Coruña
Local Institution - 0121, Pittsburgh
Local Institution - 0124, Cholargós
Local Institution - 0003, Genova
Local Institution - 0001, Milan
Local Institution - 0043, Hamburg
Local Institution - 0117, Hamburg
Local Institution - 0104, Roanoke
Local Institution - 0028, Besançon
Local Institution - 0005, Madrid
Local Institution - 0172, Málaga
Local Institution - 0008, Hanover
Local Institution - 0040, Toulouse
Local Institution - 0061, Pessac
Local Institution - 0030, Montpellier
Local Institution - 0101, Istanbul
Local Institution - 0044, Marburg
Local Institution - 0002, Padua
Local Institution - 0063, Seville
Local Institution - 0032, Nantes
Local Institution - 0007, Essen
Local Institution - 0126, Ioannina
Local Institution - 0171, Valencia
Local Institution - 0138, Lille
Local Institution - 0119, Arlington Heights
Local Institution - 0186, Bayonne
Local Institution - 0184, Strasbourg
Local Institution - 0183, Lyon
Local Institution - 0009, Heidelberg
Local Institution - 0029, Lyon
Local Institution - 0125, Heraklion
Local Institution - 0027, Paris
Local Institution - 0106, Dallas
Local Institution - 0004, Napoli
Local Institution - 0103, Denver
Local Institution - 0010, Munich
Local Institution - 0031, Poitiers
Local Institution - 0176, Limoges
Local Institution - 0059, Los Angeles
Local Institution - 0055, Catania
Local Institution - 0130, Sacramento
Local Institution - 0105, Portland
Local Institution - 0162, Shenyang
Local Institution - 0164, Changchun
Local Institution - 0180, Harbin
Local Institution - 0143, Shanghai
Local Institution - 0131, Shanghai
Local Institution - 0221, Shanghai
Local Institution - 0081, Craiova
Local Institution - 0145, Changzhou
Local Institution - 0146, Hefei
Local Institution - 0210, Jinan
Local Institution - 0165, Yantai
Local Institution - 0154, Qingdao
Local Institution - 0212, Linyi
Local Institution - 0137, Hangzhou
Local Institution - 0206, Ningbo
Local Institution - 0151, Nanchang
Local Institution - 0163, Xiamen
Local Institution - 0207, Zhangzhou
Local Institution - 0076, Cluj-Napoca
Local Institution - 0197, Changsha
Local Institution - 0181, Zhengzhou
Local Institution - 0167, Guangzhou
Local Institution - 0153, Guangzhou
Local Institution - 0149, Guangzhou
Local Institution - 0158, Foshan
Local Institution - 0160, Nanning
Local Institution - 0196, Nanning
Local Institution - 0195, Kunming
Local Institution - 0205, Iași
Local Institution - 0188, Xi'an
Local Institution - 0089, Suceava
Local Institution - 0211, Lanzhou
Local Institution - 0118, Chuo-ku
Local Institution - 0129, Minato-ku
Local Institution - 0107, Kashiwa-shi
Local Institution - 0108, Sunto-gun
Local Institution - 0109, Nagoya
Local Institution - 0177, Kurashiki
Local Institution - 0071, Santiago
Local Institution - 0116, Fukuoka
Local Institution - 0069, Santiago
Local Institution - 0133, Kumamoto
Local Institution - 0128, Kanazawa
Local Institution - 0189, Ōsaki
Local Institution - 0094, São José do Rio Preto
Local Institution - 0096, Ipatinga
Local Institution - 0200, Natal
Local Institution - 0192, Porto Alegre
Local Institution - 0102, Barretos
Local Institution - 0095, São Paulo
Local Institution - 0199, Rio de Janeiro
Local Institution - 0193, São Paulo
Local Institution - 0011, Edmonton
Local Institution - 0039, Vancouver
Local Institution - 0013, Toronto
Local Institution - 0016, Montreal
Local Institution - 0015, Sherbrooke
Local Institution - 0070, Independencia
Local Institution - 0091, Dublin
Local Institution - 0022, Dublin
Local Institution - 0087, Brno
Local Institution - 0085, Hradec Králové
Local Institution - 0088, Nový Jičín
Local Institution - 0086, Olomouc
Local Institution - 0042, Dresden
Local Institution - 0026, Limerick
Local Institution - 0054, Roma
Local Institution - 0112, Chiba
Local Institution - 0132, Matsuyama
Local Institution - 0174, Sapporo
Local Institution - 0111, Kawasaki
Local Institution - 0175, Yokohama
Local Institution - 0115, Suita-shi
Local Institution - 0187, Hidaka
Local Institution - 0110, Kitaadachigun
Local Institution - 0113, Koto-ku
Local Institution - 0114, Osaka
Local Institution - 0052, Amsterdam
Local Institution - 0051, Amsterdam
Local Institution - 0050, Utrecht
Local Institution - 0035, Oslo
Local Institution - 0058, Rio Piedras
Local Institution - 0168, Brasov
Local Institution - 0080, Bucharest
Local Institution - 0056, Badalona
Local Institution - 0006, Barcelona
Local Institution - 0092, Adana
Local Institution - 0127, London
Local Institution - 0049, Oxford
Lead Sponsor
Collaborators (1)
Ono Pharmaceutical Co. Ltd
INDUSTRY
Bristol-Myers Squibb
INDUSTRY